Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Why did the reporting for this quarter end on 1/31/2008?
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I believe that any payments due from the J2.5 during the period of the 10Q were fully accounted for........In conclusion, I do not believe that the J2.5 have made a full and final settlement......milestone

wow ! ...... it took a whole week for someone to finally spit that out in plain english....Milestone, would you consider writing the shareholders letters from now on ?

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply